Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison

ConclusionIn adults with newly diagnosed Ph  + ALL, first-line treatment with ponatinib was associated with better outcomes than first-line treatment with imatinib.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research